Skip to content

Clinical trials

Phase 2 Respiratory Distress Syndrome trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Distress Syndrome Phase: Phase 2 Country / region: Canada Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20122
20152
20202
20211
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Terminated2
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Windtree Therapeutics2
Aerogen Pharma Limited1
Arch Biopartners Inc.1
BioAegis Therapeutics Inc.1
GlaxoSmithKline1
Hamilton Health Sciences Corporation1
Ottawa Hospital Research Institute1
Unity Health Toronto1
University of Washington1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiratory Distress Syndrome10
Acute Lung Injury2
Premature Birth2
Acute Kidney Injury1
COVID-191
Critical Illness1
Edema1
Hyaline Membrane Disease1
Infections1
Multiple Trauma1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.